Clinical TrialID 8375
Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
NCT05780840
Erythropoietic Protoporphyria
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 8375
- Evidence Id
- 8375
- Core Evidence Id
- 8375
- Source Clinical Trial Id
- 8373
- Herb2 Clinical Trial Id
- HBCT008373
- Nct Id
- NCT05780840
- Title
- Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
- Status
- Recruiting
- Phase
- Study Result
- No
- Study Condition
- Erythropoietic Protoporphyria
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
- Intervention
- OTHER: Dihydroxyacetone|OTHER: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Prevention
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 6
- Outcome Measure
- Visible light exposure dose to onset of first skin symptom, Assessed by phototesting, Meassurement one day after dihydroxyacetone application
- Sponsor Collaborator
- Bispebjerg Hospital
- Funded By
- OTHER
- Location
- Ida Marie Heerfordt, Copenhagen, 2400, Denmark
- Other Id
- Dihydroxyacetone
- Start Date
- 2023-02-23
- Primary Completion Date
- 2024-09
- Completion Date
- 2024-09
- First Posted
- 2023-03-23
- Results First Posted
- Last Update Posted
- 2023-03-23
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05780840
- Title Cn
- Title En
- Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria
- Bilingual Status
- semi_complete